chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After the injection of Pfizer, I started getting dizzy and having headaches with nausea. I went to work and dealt with the sick feeling. When I went to bed that night it felt like my shot was leaking but when I wiped nothing was there. the next morning I took off the bandage and there was a blister and a red line on my arm right next to my injection site. I have documentation of what that looked like. I called my works employee health and the health department to report it. When I had covid back in february of 2021 I started having difficulty breathing. It would come and go over the past few months and was nothing super serious. I read that that will happen as a side effect of having covid. after I got my vaccine, I started having these breathing problems multiple times every day since my vaccine. I start feeling like my chest is tightening and then I can?t get enough air into my lungs and it feels like i?m underwater. I start feeling like i am going to pass out because I can?t breathe and then i get light headed and my ears will start ringing like i?m going to black out so i have to sit down and tilt my head back to open my airways. this has been happening every day since my vaccine and I need to know what tests I should do to see what?s causing this because it is effecting my ability to work. I have to stand at work and lift heavy items all day and I have been having extreme difficulty with doing those tasks at work
Within 12 hours of giving vaccines pt developed abdominal cramping.  Parents beleive it was the day after the vaccines were given that the pt developed an itchy diffuse red rash on left arm about the size of an adult hand that resembled a "wind burn"
rash; This spontaneous case was reported by a patient and describes the occurrence of RASH (rash) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (rash). At the time of the report, RASH (rash) outcome was unknown.        mRNA-1273 (Spikevax) (Unknown) dosing remained unchanged.       No concomitant medications were reported.   It was reported that patient received 4 doses of Moderna vaccine and had a rash since first dose.  No treatment details were reported.
Rotavirus vaccine given as injection instead of PO route.  Informed parents. No symptoms as of now. No treatment administered.
SIDE EFFECT; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers No concomitant medications were reported. On an unspecified date, the subject experienced side effect. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of side effect was not reported. This report was non-serious.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions and concomitant medications was reported. On an unknown date, the reporter opened a box of VARIVAX and one of the vials in the box did not have a flip cap on the vial. The flip cap was not found in the box. On an unknown date, the patient was vaccinated with a different vial of VARIVAX lot # N031939, expiry date: 13-NOV-2019, for prophylaxis (dose was not reported). No adverse symptoms were reported. Product quality complaint was involved.
Site: Redness at Injection Site-Mild, Error: Shoulder Joint Injury (prolonged pain, tingling, etc.)
Swelling in clavical area and pain and swelling in right arm.  Still occurring I am taking antibiotics and Benadryl I am having a MRI done on 01/26/2011.
flu vax & pnu-immune mixed in same syringe & inj into one site & pt devel cellulitis & was hosp;this is 1 of 2 pt from this site to devel cellulitis p/vax;
Per nursing note, patient complained of swelling and mild tenderness at site of injection. Urticaria. Pruritus and Swelling/mild tenderness.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Information regarding relevant medical history and concurrent condition were not reported. On 29-JAN-2016 the patient was vaccinated with an improperly stored dose of VARIVAX (Merck) (lot # L024250, expiration date 30-JUN-2017, dosage and route not specified). It was reported that the vaccine was stored at -13.7 degree Centigrade for 15 hours. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Patient reported radiating pain at injection site over 35 days since vaccination.  The pain is not always there but will come and go randomly when using arm.
Very painful shot  8 hours after shot started chills, fatigue, achy, nerve pain, sensitive skin, headache lasting 2 days
Information has been received from a nurse concerning a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant therapy were not reported. On 17-NOV-2016 and 27-JAN-2017, the patient was vaccinated with the first and second dose of GARDASIL 9 (lot # and expiration date unknown), intramuscularly as prophylaxis. On 04-APR-2017, the patient was vaccinated with the third dose of GARDASIL 9 (lot # reported as M0411213 and expiration date reported as 22-JUN-2019), intramuscularly as prophylaxis (administered too early, inappropriate schedule of drug administration). No adverse effects were reported.
16 year old received moderna vaccine; A spontaneous report was received from other healthcare professional (Pharmacist) concerning a 16-years-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273), on 20Feb2021.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 20 Feb 2021, the patient received their dose of mRNA-1273 (Batch Number Unknown), unknown route for prophylaxis of COVID-19 infection.  On 20 Feb 2021, 16 years old patient received moderna vaccine.  No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of event 16 years old patient received moderna vaccine was considered resolved.; Reporter's Comments: This is a case of 16-year-old patient who was administered mRNA-1273 (Inappropriate age at vaccine administration) (Batch #: unknown). There was no associated adverse event reported for the event of Inappropriate age at vaccine administration.
Child was no longer able to use the lower part of her body, could not sit up, lean forward, or use her legs.
pt recvd vax 10-11AM; running fever around 4PM; given Tempra drops; fever cont rest of wk; 3JUN94 mom put pt down for nap noon; 2PM found pt on back, blue & jerking like having a sz; took pt to ER; t105 ER;mom stated pt's ear were bulging
Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 35-year-old female patient (gravida 3) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     The patient's past medical history included Pregnancy.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 14-Mar-2021. On 28-Jan-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). On 28-Jan-2021, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment medications were provided.
12/10/2001-Onset of congestion and runny nose. No fever, no sore throat, no malaise, no muscle aches. The patient went to the doctor because they were "very prone to bronchitis" He was told that he had a cold and was prescribed Ampicillin. The patient is aware that the vaccination doesn't protect against URI. He just followed CDC's info on us (VAERS)
Patient came in for his COVID Bivalent Booster today.  The medical record showed he was due for his #1 COVID Bivalent Booster. Patient told us at the time of the visit that he hadn't had his Bivalent Booster yet.  He didn't have his COVID card with him during his MA visit today so we  didn't know if he'd had any additional COVID vaccines other than those given at clinics.   Patient agreed & signed the vaccine consent forms for both the Moderna Bivalent COVID booster and the #1 Shingrix vaccine today.  Patient left the clinic after waiting 15 mins after the vaccines.  I documented the patient's vaccines in his chart after he left the clinic because I had other patients waiting to be seen right away for MA visits.  Before I documented the vaccine, the system automatically updated and pulled in an Outside vaccination record showing he'd already had a Pfizer COVID Bivalent vaccine at Pharmacy on 9/14/22.   I reported to my manager that the patient had received a 2nd COVID Bivalent vaccine by mistake without me knowing at the time of the vaccination. Called the patient and had him look at his COVID vaccine card, that he had stored at home, and confirmed that his card does show he has had a Pfizer COVID Bivalent vaccine on 9/14/22 at Pharmacy.  Informed pt that he wasn't due for a 2nd Bivalent Booster today, so he received a 2nd dose by accident.  Informed pt that we don't believe he should have any complications from having an additional dose this soon, but we will check with health advisors about this issue today and will call him back if there are any health risks he needs to know about.   Patient stated understanding and had no further questions.
ANTHRAX WAS GIVEN AS PPD. 0.1 ANTHRAX GIVEN INSTEAD OF TST.
On 5/15/02 received DTaP. had recent illness had fever prior to shot, but now afebrile. Arm is less swollen than it was , a bit warm - 3 inch erythema.
This spontaneous report as received from a registered nurse refers to a 49 year old female patient. On an unknown date in 2003, the patient was vaccinated with first and second series of RECOMBIVAX HB, (lot number, expiry date and route was not reported). On an unknown date, the patients titers were drawn and patient showed no antibody response. There was no treatment provided. The outcome of titers was unknown. The patient did not seek medical attention. Additional information has been requested.
Hair loss started 10 hours after injection.  With in 90 minutes of dose 2 my blood pressure skyrocketed. We?re talking stroke/heart attack level blood pressure 164/145  146/119  162/100 165/105 144/106 159/102 158/116  156/122 169/152. It?s been 4 days since the second dose and my blood pressure is still high
RN states that she mistakenly administered a manectra vaccination to a patient instead of the intended MMR (with no reported adverse event); Initial information was received on 23-Feb-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 71 years old male patient who reported that RN states that she mistakenly administered a manectra vaccination to a patient instead of the intended MMR (with no reported adverse event) after receiving meningococcal a-c-y-w135 (d conj) vaccine [Menactra].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 23-Feb-2023, the patient received a dose of 0.5 ml of suspect meningococcal a-c-y-w135 (d conj) vaccine(Solution for injection) (lot U7268AA, Expiry date : 22-Apr-2023) (strength : unknown) via intramuscular route in the left deltoid for Immunization.  On 23-Feb-2023 the patient developed a non-serious event of RN states that she mistakenly administered a manectra vaccination to a patient instead of the intended MMR (with no reported adverse event) (wrong product administered) (latency: same day) following the administration of meningococcal a-c-y-w135 (d conj) vaccine.  Action taken with meningococcal vaccine (Menactra) was not applicable.  At time of reporting, the outcome was Unknown for the event RN states that she mistakenly administered a manectra vaccination to a patient instead of the intended MMR (with no reported adverse event).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
I got the shot last year got the shingles/Suspected vaccination failure; Got the Shingles just last week.; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, less than 2 years after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. The patient was treated with antibiotics nos (Antibiotics (Brand Names Not Known)). On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was recovered/resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 08-MAY-2022 Reporters comment: The patient self-reported the case via interactive digital media and described the occurrence of suspected vaccination failure. The patient received Shingles vaccine, in 2021, last year from the date of reporting. After receiving Shingles vaccine, the patient still got shingles in last week from the date of reporting. At the time of reporting, the patient was not suffering but stated that, if the doctor had not seen then, she would not be on the antibiotics. The patient stated that, actually her husband saw them first. Additional supportive information: This case was considered as suspected vaccination failure, since the details regarding completion of the primary immunization and laboratory test confirming shingles were unknown at the time of reporting.
No symptoms.  She got a 3rd dose.  She already received the 2 original doses in 2019
Third Pfizer vaccination administered Thursday Oct. 09,02021at pharmacy Left arm injections site. Very sore arm which did not happen with the first two vaccinations. Pain moved from injection site to under the left arm into the left arm lymph nodes and into nodes in my left breast. Pain. Aching, Sensitive to the pressure. I am concerned that this vaccination caused tis response.
second vaccine given yesterday, caller reports it is expired, when she looks up lot# herself; This spontaneous case was reported by a consumer and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (second vaccine given yesterday, caller reports it is expired, when she looks up lot# herself) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concurrent medical conditions included Autoimmune disorder NOS. Concomitant products included ATENOLOL (TENORMIN) for an unknown indication.    In 2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (second vaccine given yesterday, caller reports it is expired, when she looks up lot# herself). In 2021, EXPIRED PRODUCT ADMINISTERED (second vaccine given yesterday, caller reports it is expired, when she looks up lot# herself) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported. Medical conditions includes Cardiac.
she had regular periods more than a year and she had not missed any and she is 7 to 10 days late and it's only happened since she got her vaccine/ delayed on her periods; This is a spontaneous report from a contactable nurse via medical information team. A 13-year-old female patient received second dose of bnt162b2 (COMIRNATY, Solution for injection, Batch/Lot number was not reported, NDC number, UPC number, expiry date was reported as unknown) via an unspecified route of administration on an unspecified date as dose 2, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received her second dose of the Pfizer-BioNTech covid-19 vaccine. Since then, she had not had her period and was 7-10 days late. It was reported she had regular periods more than a year and she had not missed any and she was 7 to 10 days late and it's only happened since she got her vaccine. Reporter also reported that she has friend whose daughter had received the vaccine already but then after her daughter had received the vaccine and she did not gap a period since she got the vaccine. But there was a delayed on her periods. Causality noted and reporter stated, might be a possibility her mom said she had period. So, reporter meant a possibility, reporter meant non other are reasons why it could be late so, she was concerned about it, reporter was trying to ease her little bit. HCP said she has read that some people did report of the same reaction, and it was resolved in about 2-3 months. She wanted to know if this was something that people have reported with the vaccine. Nurse was informed about the Pfizer medical information department. Outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
back pain; pain right rib area; This spontaneous case was reported by a patient and describes the occurrence of BACK PAIN (back pain) and MUSCULOSKELETAL CHEST PAIN (pain right rib area) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, the patient experienced BACK PAIN (back pain) and MUSCULOSKELETAL CHEST PAIN (pain right rib area). At the time of the report, BACK PAIN (back pain) and MUSCULOSKELETAL CHEST PAIN (pain right rib area) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt woke up on 3/8/17 with area where injection was given red, hard and warm to touch. Area itchy as well. Ice applied and hct.cream as well. Mom said area of redness measured approx. 6in x 4in. Area totally resolved by Saturday 3/11/17.
Resident received monoclonial Regen-CO antibodies on 8.27.2021 and then was given the Pfizer booster COVID-19 vaccine on 10.11.21 which is before the 90 day recommendation. No adverse effects observed. Vital signs stable. Continued monitoring in place.
Noticed  I scratched my abdomen but did not know why on friday/sat ... woke up sunday morning and and saw hives around neckline, over umbilical area and all over upper thighs.  They have not gone away with cetirizine or benadryl 25 mg as of yet.
9/22/18 6:30 AM She woke up with a headache, swollen tongue and trouble talking and thinking. After that she had a mild headache daily until it got worse on 9/27/18. I took my daughter to the ER at 6:30 PM for meds to relieve the headache, they did not work and I had her at a different ER on 9/29/18 at 2:30 AM for the pain. This ER sent her to a pediatric hospital to be admitted. She stayed the night in Hospital and received meds via IV to get relief from the pain. She was back in the ER on 10/10/18 due to yet another migraine that this time involved hand tingling and mouth tingling. She once again received an IV and fluids and medication. She was released the same day and we followed up with a neurologist on 10/11/18 where she has been put on a daily medication to try to limit the amount of headaches that she gets. She now has headaches daily and lives in fear of a bad one that will possibly land her back in the hospital. Prior to getting the GARDASIL vaccine my daughter was healthy and did not have migraines. Before this vaccine she rarely even got a headache at all, much less one that we couldn't get rid of!!!
noted increase in shortness of breath, needing to use rescue inhaler more frequently than normal- visit to doctor initial thought was upper respetory infection, prescribed Zpack and prednisone,.  After 10 days from start of meds still do not feel well.
Information has been received from a certified medical assistant (C.M.A.) concerning a 17 week old female who on 22-JAN-2009 was vaccinated orally with a first dose of ROTATEQ "after the 6-12 weeks of age". No adverse effects reported. The patient sought medical attention at physician's office. Additional information has been requested.
Lump; painful lump; Wrong route of Administration; This case was reported by a pharmacist via call center representative and described the occurrence of skin mass in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix (subcutaneous). On an unknown date, less than 3 months after receiving Shingrix, the patient experienced skin mass, pain and intramuscular formulation administered by other route. On an unknown date, the outcome of the skin mass and pain were not recovered/not resolved and the outcome of the intramuscular formulation administered by other route was unknown.   It was unknown if the reporter considered the skin mass and pain to be related to Shingrix.  Additional details were provided as follows: The dose of Shingrix was administered subcutaneously which led to intramuscular formulation administered by other route. The patient received dose one approximately three months ago, no exact date provided. It was patient experienced a lump following dose one of Shingrix.  The health care professional described the lump as painful Lump was ongoing, no additional details were provided. The health care professional could not provide lot number or expiration date because the patient received dose one at another location.  No additional details provided. The reporter consented to follow up.
15 Minutes after injection: facial numbness on left side, neck, jaw and ear pain, Rash from face to legs. 24 Hours After: Muscle Tension, headache, light headed, chills
The pt experienced an immediate flushing reaction characterized by red blotches on her chest and cheeks which were not raised and were transient. Unspecified medical attention was sought.
The patient had a local reaction on the left leg the evening after the immunization in an area over the upper thigh the size of a small baseball. It was red and warm to the touch. The patient was fussy but did not have a fever or other adverse reaction. Motrin was advised for treatment
My left arm/ shoulder is extremely sore since the shot on 4-1.  7 weeks ago.  It does not seam to be improving as days go by.